Immunology and Microbiology
Vaccine Efficacy
100%
Immunotherapy
89%
T Cell
79%
Immune Response
53%
Cytotoxic T-Cell
45%
Mouse
43%
Granulocyte Macrophage Colony-Stimulating Factor
39%
Cancer Vaccine
36%
Tumor Cell
33%
Tumor Vaccine
29%
Tumor Antigen
29%
Vaccination Policy
26%
Cancer Immunotherapy
23%
Cyclophosphamide
21%
Cytokine
20%
Overall Survival
20%
Immunocompetent Cell
18%
Whole Cell
18%
Pancreas
17%
Immune System
17%
Immunosuppressive Drug
16%
Neoantigen
15%
Monospecific Antibody
15%
Regulatory T Cell
15%
Mesothelin
14%
Monoclonal Antibody
14%
Programmed Death-Ligand 1
14%
Cancer Cell
13%
Dendritic Cell
13%
CD8
13%
CD4
12%
Tumor Cell Vaccine
12%
Myeloid
12%
Adoptive Immunity
11%
T-Helper Cell
11%
Antigen Specificity
11%
Arm
10%
Agonist
9%
Cell Infiltration
9%
Immune Tolerance
9%
Macrophage
9%
Mouse Model
8%
Transgenic Mouse
8%
Tumor Immunology
8%
T Cell Receptor
8%
Colon
8%
Immunity
8%
Nivolumab
8%
B Cell
8%
Cancer Associated Fibroblast
8%
Medicine and Dentistry
Neoplasm
92%
Pancreas Adenocarcinoma
86%
Pancreas Cancer
81%
Immunotherapy
59%
Malignant Neoplasm
51%
T Cell
43%
Tumor Microenvironment
35%
Clinical Trial
23%
Pancreas Tumor
21%
Granulocyte Macrophage Colony Stimulating Factor
20%
Immune Response
20%
Cancer Vaccine
19%
Tumor Vaccine
18%
Cytotoxic T-Cell
18%
Hepatocellular Carcinoma
18%
Cancer Immunotherapy
17%
Disease
17%
Mesothelin
17%
Biological Marker
16%
Metastatic Carcinoma
16%
Tumor Cell
15%
Overall Survival
15%
Tumor Antigen
13%
Arm
13%
Nivolumab
13%
Recurrent Disease
11%
Cyclophosphamide
11%
Ipilimumab
11%
Programmed Death-Ligand 1
11%
Surgery
11%
Stroma
10%
Breast Cancer
10%
Monoclonal Antibody
10%
Colorectal Cancer
10%
Whole Cell
10%
Specific Tumor
10%
CD8 Antigen
9%
Cell Line
9%
Cancer Therapy
9%
Immune Checkpoint Inhibitor
9%
Entinostat
9%
Pancreatic Ductal Adenocarcinoma
9%
Cytokine
8%
Cancer Cell
8%
Oncology
8%
Immunosuppressive Drug
8%
Macrophage
8%
Breast Tumor
8%
T-Cell Response
8%
Cellular Infiltration
8%
Keyphrases
Tumor
65%
Pancreatic Cancer
50%
Pancreatic Ductal Adenocarcinoma
43%
Therapeutic Vaccine
39%
Tumor Microenvironment
31%
Granulocyte Colony-stimulating Factor (G-CSF)
29%
Pancreatic Adenocarcinoma
24%
Allogeneic
23%
T Cells
23%
Cancer Vaccine
22%
Tumor Immunity
22%
CD8+ T Cells
20%
Tumor Cells
19%
Tumor Antigen
19%
Pancreatic Tumor
18%
Antitumor Immune Response
18%
Clinical Trials
18%
Overall Survival
17%
Cancer Immunotherapy
16%
Cyclophosphamide
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
14%
Nivolumab
13%
Neoantigen
13%
Programmed Death-ligand 1 (PD-L1)
12%
Metastatic Pancreatic Ductal Adenocarcinoma
12%
Chemotherapy
12%
Immune Checkpoint Inhibitors
11%
Immune Response
11%
In Cancer
11%
Cancer Treatment
11%
Neoadjuvant
10%
Metastasis
10%
Clinical Response
10%
Vaccination
10%
Immune Regulation
10%
Pancreas
10%
T Cell Activation
10%
Anti-tumor Response
9%
Mesothelin
9%
Hepatocellular Carcinoma
9%
Colorectal Cancer
9%
Tumor Growth
9%
Effector T Cells
9%
Patients with Cancer
9%
Immune Activation
9%
Monoclonal Antibody
8%
Ipilimumab
8%
Cancer Cells
8%
Antigen-specific
8%
Immune Tolerance
7%
